139 related articles for article (PubMed ID: 6501724)
21. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.
Packer M; Medina N; Yushak M
J Am Coll Cardiol; 1984 Nov; 4(5):890-901. PubMed ID: 6491082
[TBL] [Abstract][Full Text] [Related]
22. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
Townend JN; Doran J; Lote CJ; Davies MK
Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658
[TBL] [Abstract][Full Text] [Related]
23. Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension.
Rich S; Ganz R; Levy PS
Am J Cardiol; 1983 Nov; 52(8):1104-7. PubMed ID: 6637831
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic effects of sublingual nifedipine in congestive heart failure.
Matsui S; Murakami E; Takekoshi N; Hiramaru Y; Murakami H; Kitano E; Masuya K; Saga T; Nomura M; Fujita S; Tsuji S
Jpn Circ J; 1979 Dec; 43(12):1081-8. PubMed ID: 541827
[TBL] [Abstract][Full Text] [Related]
25. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
[TBL] [Abstract][Full Text] [Related]
26. Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure.
LeJemtel TH; Elkayam U; Ribner HS; Hellman C; Strom J; Frishman W; Strobeck J; Sonnenblick EH
Eur Heart J; 1980 Jun; 1(3):157-63. PubMed ID: 7026250
[No Abstract] [Full Text] [Related]
27. The effects of oral hydralazine on right ventricular end-diastolic pressure in patients with right ventricular failure.
Rubin LJ; Handel F; Peter RH
Circulation; 1982 Jun; 65(7):1369-73. PubMed ID: 7074795
[TBL] [Abstract][Full Text] [Related]
28. Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study.
Bragadottir G; Redfors B; Ricksten SE
Crit Care Med; 2013 Oct; 41(10):2328-35. PubMed ID: 23921271
[TBL] [Abstract][Full Text] [Related]
29. Effects of prolonged infusion of human alpha calcitonin gene-related peptide on hemodynamics, renal blood flow and hormone levels in congestive heart failure.
Shekhar YC; Anand IS; Sarma R; Ferrari R; Wahi PL; Poole-Wilson PA
Am J Cardiol; 1991 Apr; 67(8):732-6. PubMed ID: 2006623
[TBL] [Abstract][Full Text] [Related]
30. Static exercise with congestive heart failure and the response to vasodilating drugs.
Broudy DR; Greenberg BH; Siemienczuk D; Reinhart S; Morris C; Demots H
Am J Cardiol; 1987 Jan; 59(1):100-4. PubMed ID: 3812218
[TBL] [Abstract][Full Text] [Related]
31. Hemodynamic effects of nifedipine on secondary pulmonary hypertension in man.
Garzaniti N; el Allaf D; D'Orio V; Cremers S; Marcelle R; Carlier J
Acta Cardiol; 1985; 40(2):207-15. PubMed ID: 3873156
[TBL] [Abstract][Full Text] [Related]
32. Comparison of antihypertensive, renal hemodynamic, and humoral effects of pinacidil and hydralazine monotherapy.
Abraham PA; Halstenson CE; Matzke GR; Keane WF
J Clin Hypertens; 1987 Dec; 3(4):439-51. PubMed ID: 3330986
[TBL] [Abstract][Full Text] [Related]
33. Effects of nisoldipine on systemic and leg blood flow, oxygen transport and metabolism, and hemodynamics during exercise in effort angina pectoris.
Ram J; Freedman SB; Ogasawara S; Thomson A; Kelly DT
Am J Cardiol; 1989 Apr; 63(12):802-6. PubMed ID: 2929436
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients.
Franciosa JA; Pierpont G; Cohn JN
Ann Intern Med; 1977 Apr; 86(4):388-93. PubMed ID: 848799
[TBL] [Abstract][Full Text] [Related]
35. Haemodynamic effect of sublingual nifedipine in patients with congestive heart failure.
Wasir HS; Sood AK
Indian Heart J; 1984; 36(1):8-14. PubMed ID: 6706374
[No Abstract] [Full Text] [Related]
36. Felodipine. A calcium-inhibiting vasodilator in refractory hypertension.
Andersson OK; Granérus G; Hedner T
Drugs; 1985; 29 Suppl 2():102-8. PubMed ID: 3886356
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandins participate in the renal vasodilation due to hydralazine in dogs.
Panzenbeck M; Baez A; Kaley G
J Pharmacol Exp Ther; 1986 May; 237(2):525-8. PubMed ID: 3084759
[TBL] [Abstract][Full Text] [Related]
38. Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination.
Leier CB; Magorien RD; Desch CE; Thompson MJ; Unverferth DV
Circulation; 1981 Jan; 63(1):102-9. PubMed ID: 7438384
[TBL] [Abstract][Full Text] [Related]
39. Acute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure.
Cogan JJ; Humphreys MH; Carlson CJ; Benowitz NL; Rapaport E
Circulation; 1981 Nov; 64(5):973-6. PubMed ID: 7285311
[TBL] [Abstract][Full Text] [Related]
40. [Non-invasive regional and cardiac output determination in healthy volunteers. Predictive value].
Thuillez C; Leroy JP; Loueslati H; Bellissant E; Giudicelli JF
Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1275-9. PubMed ID: 2510661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
